Skip to main content
SpringerLink
Log in

Proliferation characteristics of CD133+ cell population in colorectal cancer

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

In this study, CD133+ subpopulations were isolated from 41 primary colorectal cancer tissues, the proliferation and cell cycle distribution of the cells were examined without in vitro expansion, and then compared to those of cell lines. The detection of CD133 in colorectal cancer tissues, isolation of CD133+ and CD133− epithelial subpopulations, Ki-67/DNA multiparameter assay and cell volume analysis were flow cytometrically conducted. The results showed that Ki-67 expression was correlated with CD133 level in primary cancer tissues, while cell cycle G2/M phase distribution or clinicopathological characteristics was not. In addition, the CD133+ cells showed larger cell volume and higher Ki-67 expression as compared with CD133− cells. But there was no statistically significant difference in G2/M phase distribution between the two subpopulations. Our results demonstrated that the CD133+ subpopulation in colorectal cancer tissue contained more actively cycling and proliferating cells, which was not correlated to clinicopathological factors but might contribute to tumor progression and poor clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tirino V, Desiderio V, d’Aquino R, et al. Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One, 2008, 3(10):e3469

    Article  PubMed  Google Scholar 

  2. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol, 2007, 18(5):460–466

    Article  CAS  PubMed  Google Scholar 

  3. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene, 2004, 23(43):7274–7282

    Article  CAS  PubMed  Google Scholar 

  4. Weigmann A, Corbeil D, Hellwig A, et al. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA, 1997, 94(23):12425–12430

    Article  CAS  PubMed  Google Scholar 

  5. Miraglia S, Godfrey W, Yin AH, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood, 1997, 90(12):5013–5021

    CAS  PubMed  Google Scholar 

  6. Fargeas CA, Corbeil D, Huttner WB. AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature. Stem Cells, 2003, 21(4):506–508

    Article  CAS  PubMed  Google Scholar 

  7. Kobari L, Giarratana MC, Pflumio F, et al. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells. J Hematother Stem Cell Res, 2001, 10(2):273–281.

    Article  CAS  PubMed  Google Scholar 

  8. Zheng W, Wan Y, Ma X, et al. Isolation of cultured endothelial progenitor cells in vitro from PBMCs and CD133(+) enriched cells. J Huazhong Univ Sci Technolog [Med Sci], 2010, 30(1):18–24

    Article  Google Scholar 

  9. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature, 2004, 432(7015):396–401

    Article  CAS  PubMed  Google Scholar 

  10. Singh SK, Clarke ID, Hide T, et al. Cancer stem cells in nervous system tumors. Oncogene. 2004, 23(43): 7267–7273

    Article  CAS  PubMed  Google Scholar 

  11. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 2005, 65(23):10946–10951

    Article  CAS  PubMed  Google Scholar 

  12. Wei C, Guomin W, Yujun L, et al. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Cancer Biol Ther, 2007, 6(5):763–768

    Article  CAS  PubMed  Google Scholar 

  13. Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology, 2007, 132(7):2542–2556

    Article  CAS  PubMed  Google Scholar 

  14. Yin S, Li J, Hu C, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer, 2007, 120(7):1444–1450

    Article  CAS  PubMed  Google Scholar 

  15. O’Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007, 445(7123):106–110

    Article  PubMed  Google Scholar 

  16. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancerinitiating cells. Nature, 2007, 445(7123): 111–115

    Article  CAS  PubMed  Google Scholar 

  17. Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 2007, 1(3):313–323

    Article  CAS  PubMed  Google Scholar 

  18. Immervoll H, Hoem D, Sakariassen PO, et al. Expression of the stem cell marker CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer, 2008, 8:48

    Article  PubMed  Google Scholar 

  19. Jaksch M, Munera J, Bajpai R, et al. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res, 2008, 68(19):7882–7886

    Article  CAS  PubMed  Google Scholar 

  20. Xie DX, Yao J, Zhang P, et al. Are progenitor cells pre-programmed for sequential cell cycles not requiring cyclins D and E and activation of Cdk2? Cell Prolif, 2008, 41(2):265–278

    Article  CAS  PubMed  Google Scholar 

  21. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med, 2006, 355(12):1253–1261

    Article  CAS  PubMed  Google Scholar 

  22. Horst D, Kriegl L, Engel J, et al. CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer, 2008, 99(8):1285–1289

    Article  CAS  PubMed  Google Scholar 

  23. Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133− metastatic colon cancer cells initiate tumors. J Clin Invest, 2008, 118(6):2111–2120

    CAS  PubMed  Google Scholar 

  24. LaBarge MA, Bissell MJ. Is CD133 a marker of metastatic colon cancer stem cells? J Clin Invest, 2008, 118(6):2021–2024

    CAS  PubMed  Google Scholar 

  25. Ieta K, Tanaka F, Haraguchi N, et al. Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol, 2008, 15(2):638–648

    Article  PubMed  Google Scholar 

  26. Ma YL, Peng JY, Zhang P, et al. Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer. Med Oncol, 2010, 27(2):304–309

    Article  PubMed  Google Scholar 

  27. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A, 2007, 104(24):10158–10163

    Article  CAS  PubMed  Google Scholar 

  28. Shi X, Yuan X, Tao D, et al. Analysis of DNA ploidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometry. J Huazhong Univ Sci Technol [Med Sci], 2005, 25(2):198–201

    Article  CAS  Google Scholar 

  29. Araujo SE, Bernardo WM, Habr-Gama A, et al. DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum, 2007, 50(11):1800–1810

    Article  PubMed  Google Scholar 

  30. Kusumbe AP, Bapat SA. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res, 2009, 69(24):9245–9253

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Dongdong Yu  (于冬冬), Yonghong Zhang  (张永红), You Zou  (邹 游), Jichao Qin  (覃吉超), Xiaolan Li  (李小兰), Hui Xiao  (肖 徽), Deding Tao  (陶德定), Junbo Hu  (胡俊波) & Jianping Gong  (龚建平)

Authors
  1. Dongdong Yu  (于冬冬)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yonghong Zhang  (张永红)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. You Zou  (邹 游)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jichao Qin  (覃吉超)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaolan Li  (李小兰)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hui Xiao  (肖 徽)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Deding Tao  (陶德定)
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Junbo Hu  (胡俊波)
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jianping Gong  (龚建平)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jianping Gong  (龚建平).

Additional information

This project was supported by grants from 973 program from Ministry of Science and Technology of China (No. 2004CB518705, No. 2009CB521802), the National Natural Sciences Foundation of China (Nos. 30872472, 30800569).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, D., Zhang, Y., Zou, Y. et al. Proliferation characteristics of CD133+ cell population in colorectal cancer. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 30, 751–756 (2010). https://doi.org/10.1007/s11596-010-0652-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-010-0652-9

Key words

Search

Navigation